Skip to main content

Table 6 Intention-to-treat analysis for quality of life

From: Treatment with pirfenidone for two years decreases fibrosis, cytokine levels and enhances CB2 gene expression in patients with chronic hepatitis C

Domains (mean ± SD) SF-36* before SF-36* after P value
Physical function 69 ± 30 82 ± 23 0.00**
Role physical 61 ± 47 86 ± 32 0.02**
Body pain 70 ± 26 81 ± 19 0.00**
General health 55 ± 21 73 ± 18 0.00**
Vitality 62 ± 24 73 ± 22 0.02**
Social functioning 73 ± 29 81 ± 23 0.03**
Role emotional 68 ± 45 83 ± 38 0.17
Mental health 75 ± 20 83 ± 17 0.00**
  1. *SF-36: Short-Form Health Survey with 36 questions. **p < 0,05.